Literature DB >> 10852746

Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

A O Magnan1, L G Mély, C A Camilla, M M Badier, F A Montero-Julian, C M Guillot, B B Casano, S J Prato, V Fert, P Bongrand, D Vervloet.   

Abstract

Atopy is characterized by an immune system that is biased to T helper cell, type 2 (Th2) activation. This condition predisposes to asthma, a disease in which a Th2 activation was found in blood and lungs. However, most blood studies have considered purified cells, which might give an incomplete view of immune reactions. In this study, we assessed in whole blood cultures the Th1/Th2 paradigm in atopy and asthma. Sixty-nine subjects (31 atopic asthmatics, six nonatopic asthmatics, 13 atopic nonasthmatics, and 19 control subjects) were included in this study. Interleukin-4 (IL-4), interferon gamma (IFN-gamma), and IL-12 were assayed in stimulated whole blood culture supernatants by using a flow cytometer microsphere-based assay. Intracellular IL-4 and IFN-gamma were detected in T cells and CD8(+) T cells by flow cytometry. Atopy was characterized by a higher production of IL-4, which was correlated to total IgE levels, and by an impairment of the T-cell capacity to produce IFN-gamma. This impairment was correlated to the number of positive skin tests. In asthma, the overproduction of IL-4 was still found if atopy was present. Unexpectedly, an overproduction of IFN-gamma was found, which was related to an increased capacity of CD8(+) T cells to produce IFN-gamma. The number of IFN-gamma-producing CD8(+) T cells was related to asthma severity, to bronchial hyperresponsiveness, and to blood eosinophilia. In addition, this number was correlated to IL-12 production. These results show that in addition to the well-known Th2 inflammation in asthma, there are IFN-gamma-producing CD8(+) T cells in the blood, possibly controlled by IL-12.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852746     DOI: 10.1164/ajrccm.161.6.9906130

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  53 in total

1.  Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).

Authors:  M J Leckie; G R Jenkins; J Khan; S J Smith; C Walker; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

2.  Microbial exposures in infancy predict levels of the immunoregulatory cytokine interleukin-4 in Filipino young adults.

Authors:  Paula Skye Tallman; Christopher Kuzawa; Linda Adair; Judith B Borja; Thomas W McDade
Journal:  Am J Hum Biol       Date:  2012-02-05       Impact factor: 1.937

Review 3.  Gene expression profiling in human asthma.

Authors:  Nadia N Hansel; Gregory B Diette
Journal:  Proc Am Thorac Soc       Date:  2007-01

4.  Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.

Authors:  Bryan M Grogan; Laura Tabellini; Barry Storer; Tara E Bumgarner; Claudia C Astigarraga; Mary E D Flowers; Stephanie J Lee; Paul J Martin; Edus H Warren; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-24       Impact factor: 5.742

5.  Differentiating asthma phenotypes in young adults through polyclonal cytokine profiles.

Authors:  Edward Zoratti; Suzanne Havstad; Ganesa Wegienka; Charlotte Nicholas; Kevin R Bobbitt; Kimberley J Woodcroft; Dennis R Ownby; Christine Cole Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-05       Impact factor: 6.347

6.  Multi-allergen challenge stimulates steriod-resistant airway inflammation via NF-κB-mediated IL-8 expression.

Authors:  Renping Liu; Jinye Bai; Guoshun Xu; Lingling Xuan; Tianqi Zhang; Aiming Meng; Qi Hou
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.

Authors:  Chan-Sun Park; Tae-Bum Kim; Keun Ae Moon; Yun-Jeong Bae; Hee Ran Lee; Min Kyoung Jang; Hee-Bom Moon; You Sook Cho
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

8.  Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling.

Authors:  Elizabeth R Jarman; Jonathan R Lamb
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines.

Authors:  Moe Akahira-Azuma; Marian Szczepanik; Ryohei F Tsuji; Regis A Campos; Atsuko Itakura; Narciss Mobini; Jennifer McNiff; Ivana Kawikova; Bao Lu; Craig Gerard; Jordan S Pober; Philip W Askenase
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

10.  Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways.

Authors:  You-Sun Kim; Sung-Wook Hong; Jun-Pyo Choi; Tae-Seop Shin; Hyung-Geun Moon; Eun-Jung Choi; Seong Gyu Jeon; Sun-Young Oh; Yong Song Gho; Zhou Zhu; Yoon-Keun Kim
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.